Skip to main content
. 2019 Oct 31;10(4):10.24926/iip.v10i4.1660. doi: 10.24926/iip.v10i4.1660

Exhibit 5. Extemporaneous preparation or compounding standards as set out in the Medicines [44].

  • A product is extemporaneously prepared only when there is no product with a marketing authorization available and where you are able to prepare the product in compliance with accepted standards.

  • Staff involved are competent to undertake the tasks to be performed.

  • The requisite facilities and equipment are available. Equipment must be maintained in good order to ensure that performance is unimpaired, and must be fit for the intended purpose.

  • The professional associate (Pharmacist) is satisfied as to the safety and appropriateness of the formula of the product.

  • Ingredients are sourced from recognized pharmaceutical manufacturers and are of a quality accepted for use in the preparation and manufacture of pharmaceutical products. Where appropriate, relevant legislation must be complied with.

  • Particular attention and care are paid to substances which may be hazardous and require special handling techniques.

  • The product is labelled with the necessary particulars, including an expiry date and any special requirements for the safe handling or storage of the product.

  • If you are undertaking large-scale preparation of medicinal products, all relevant standards and guidance are adhered to.

  • Records are kept for a minimum of 2 years. The records must include: the formula; the ingredients; the quantities used; their source; the batch number; the expiry date; where the preparation is dispensed in response to a prescription, the patient’s and prescription details and the date of dispensing; the personnel involved, including the identity of the pharmacist taking overall responsibility.